Tag: EU CTR 536/2014

Multi-Country Clinical Trials in the European Union

Posted on digi By digi

Multi-Country Clinical Trials in the European Union Coordinating Multi-Nation Clinical Trials in the EU: A Regulatory Perspective The European Union (EU) presents a unique opportunity for conducting high-quality, multi-country clinical trials owing to its diverse population, robust healthcare systems, and evolving regulatory frameworks. Historically, sponsors faced challenges due to inconsistent national regulations and ethics procedures,…

Read More “Multi-Country Clinical Trials in the European Union” »

Clinical Trials in EU, Country-Specific Clinical Trials

EU Clinical Trials Information System (CTIS) Explained

Posted on digi By digi

EU Clinical Trials Information System (CTIS) Explained Comprehensive Overview of the CTIS Portal for EU Clinical Trial Applications The EU Clinical Trials Information System (CTIS) is the cornerstone of the new centralized approach to clinical trial submissions and regulatory communication in the European Union. Developed and managed by the European Medicines Agency (EMA), CTIS is…

Read More “EU Clinical Trials Information System (CTIS) Explained” »

Clinical Trials in EU, Country-Specific Clinical Trials

Understanding EMA’s Role in Clinical Trial Authorization

Posted on digi By digi

Understanding EMA’s Role in Clinical Trial Authorization How the EMA Supports and Coordinates Clinical Trial Authorizations in the EU The European Medicines Agency (EMA) plays a critical role in the harmonized framework for clinical trial authorization across the European Union (EU). Under Regulation (EU) No. 536/2014—commonly known as the Clinical Trial Regulation (CTR)—the EMA has…

Read More “Understanding EMA’s Role in Clinical Trial Authorization” »

Clinical Trials in EU, Country-Specific Clinical Trials

Clinical Trial Regulation EU No. 536/2014 Explained: A Guide for Sponsors and Investigators

Posted on digi By digi

Clinical Trial Regulation EU No. 536/2014 Explained: A Guide for Sponsors and Investigators Demystifying Clinical Trial Regulation EU No. 536/2014: A Sponsor’s Guide Clinical Trial Regulation (CTR) EU No. 536/2014, which came into effect in January 2022, revolutionized the way clinical trials are conducted and authorized across the European Union (EU). The regulation replaces the…

Read More “Clinical Trial Regulation EU No. 536/2014 Explained: A Guide for Sponsors and Investigators” »

EMA (European Medicines Agency) Guidelines, Regulatory Guidelines